IYXI Inyx Inc. featured news, full reports, and detailed charts
Inyx Inc. (IYXI/IYXI.PK) Wrap Up:
Inyx, Inc., through its wholly-owned subsidiaries, operates as a specialty pharmaceutical company in the United States, Canada, and Europe. It develops and manufactures prescription and over-the-counter pharmaceutical products. The company manufactures hydrocarbon aerosols, a delivery system for dermatological and topical drug applications; metered dose inhalers that are used for respiratory conditions; dry powdered inhalers used for respiratory ailments; metered dose nasal and throat pumps, and sprays; and sterile salines and injectables. It focuses on research and development activities on inhalation-therapy drug delivery devices and inhalation methods, and generic prescription, and over-t...Inyx Inc. (IYXI:OTC)
|
Market Cap
159.3K
|
Total Revenue
85.0M
|
|
|
EBITDA
11.4M
|
DILUTED EPS TTM
-0.77
|
|
|
P/E
--
|
P/S
0.0x
|
|
|
Return On Asset
-11.73
|
Return On Equity
121.45
|
|
| K = Thousands M = Millions B = Billions | ||
IYXI Top Compensated Officers
Executives, Board Directors
Key developments for Inyx Inc. (IYXI)
Coughlin Stoia Geller Rudman & Robbins LLP announced that a class action has been commenced in the United States District Court for the Southern District of New York by an institutional investor on behalf of purchasers of Inyx Inc. common stock during the period between March 31, 2005 and July 2, 2007. The complaint charges Inyx and certain of its officers and directors, among others, with violations of the Securities Exchange Act of 1934. Inyx is a pharmaceutical company that develops and manufactures prescription and over-the-counter pharmaceutical products. The complaint alleges that, during the Class Period, defendants made numerous statements about the Company's financial performance in both its public statements and in the filings that it made with the Securities and Exchange Commission.
IYXI Competitors
| Company | Last | Change | |
| No competitor information is available for IYXI. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | IYXI | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 0.0x |
|
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | NM | Not Meaningful |
|
IYXI |
||
IYXI transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||